1
|
Genovese F, Gonçalves I, Holm Nielsen S, Karsdal MA, Edsfeldt A, Nilsson J, Shore AC, Natali A, Khan F, Shami A. Plasma levels of PRO-C3, a type III collagen synthesis marker, are associated with arterial stiffness and increased risk of cardiovascular death. Atherosclerosis 2024; 388:117420. [PMID: 38128431 DOI: 10.1016/j.atherosclerosis.2023.117420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/11/2023] [Revised: 11/17/2023] [Accepted: 12/07/2023] [Indexed: 12/23/2023]
Abstract
BACKGROUND AND AIMS The N-terminal propeptide of type III collagen (PRO-C3) assay measures a pro-peptide released during type III collagen synthesis, an important feature of arterial stiffening and atherogenesis. There is a clinical need for improved non-invasive, cheap and easily accessible methods for evaluating individuals at risk of cardiovascular disease (CVD). In this study, we investigate the potential of using circulating levels of PRO-C3 to mark the degree of vascular stenosis and risk of cardiovascular events. METHODS Baseline plasma levels of PRO-C3 were measured by ELISA in subjects belonging to the SUrrogate markers for Micro- and Macro-vascular hard endpoints for Innovative diabetes Tools (SUMMIT) cohort (N = 1354). Associations between PRO-C3 levels with vascular characteristics, namely stiffness and stenosis, and risk of future cardiovascular events were explored. Subjects were followed up after a median of 35 months (interquartile range 34-36 months), with recorded outcomes cardiovascular death and all-cause mortality. RESULTS We found a correlation between PRO-C3 levels and pulse wave velocity (rho 0.13, p = 0.000009), a measurement of arterial stiffness. Higher PRO-C3 levels were also associated with elevated blood pressure (rho 0.07, p = 0.014), as well as risk of cardiovascular mortality over a three-year follow-up period (OR 1.56, confidence interval 1.008-2.43, p = 0.046). CONCLUSIONS Elevated circulating PRO-C3 levels are associated with arterial stiffness and future cardiovascular death, in the SUMMIT cohort, suggesting a potential value of PRO-C3 as a novel marker for declining vascular health.
Collapse
Affiliation(s)
| | - Isabel Gonçalves
- Dept. of Clinical Sciences Malmö, Lund University, Clinical Research Center, Jan Waldenströms Gata 35, 214 28, Malmö, Sweden; Dept. of Cardiology, Malmö, Skåne University Hospital, Lund University, Carl-Bertil Laurells Gata 9, 214 28, Malmö, Sweden
| | - Signe Holm Nielsen
- Nordic Bioscience, Herlev Hovedgade 205-207, 2730, Herlev, Denmark; Biomedicine and Biotechnology, Technical University of Denmark, Søltofts Pl. 221, 2800, Kongens Lyngby, Denmark
| | - Morten A Karsdal
- Nordic Bioscience, Herlev Hovedgade 205-207, 2730, Herlev, Denmark
| | - Andreas Edsfeldt
- Dept. of Clinical Sciences Malmö, Lund University, Clinical Research Center, Jan Waldenströms Gata 35, 214 28, Malmö, Sweden; Dept. of Cardiology, Malmö, Skåne University Hospital, Lund University, Carl-Bertil Laurells Gata 9, 214 28, Malmö, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Klinikgatan 32, 221 84, Lund, Sweden
| | - Jan Nilsson
- Dept. of Clinical Sciences Malmö, Lund University, Clinical Research Center, Jan Waldenströms Gata 35, 214 28, Malmö, Sweden
| | - Angela C Shore
- Diabetes and Vascular Medicine, University of Exeter, Medical School, National Institute for Health Research Exeter Clinical Research Facility, Barrack Road, Exeter, EX2 5AX, UK
| | - Andrea Natali
- Department of Clinical and Experimental Medicine, University of Pisa, Via Savi 8, 56100, Pisa, Italy
| | - Faisel Khan
- Division of Systems Medicine, University of Dundee, Dundee, DD1 9SY, UK
| | - Annelie Shami
- Dept. of Clinical Sciences Malmö, Lund University, Clinical Research Center, Jan Waldenströms Gata 35, 214 28, Malmö, Sweden.
| |
Collapse
|
2
|
Fiorucci S, Urbani G. GDF15 in Vascular and Liver Metabolic Disorders: A Novel Therapeutic Target. RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY 2022; 16:55-59. [PMID: 36578252 DOI: 10.2174/277227081602221221113442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Revised: 11/30/2022] [Accepted: 12/05/2022] [Indexed: 12/24/2022]
Affiliation(s)
- Stefano Fiorucci
- Dipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy
| | - Ginevra Urbani
- Dipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy
| |
Collapse
|